2016The Professional Medical JournalOpen access

PREGNANCY INDUCED HYPERTENSION; TO COMPARE EFFICACY OF METHYLDOPA AND LABETALOL IN MANAGEMENT

Nadia Sharif, Irum Usman, Tasneem Azhar

Open full text 2 citations

Abstract

Introduction: The hypertensive Disorders of pregnancy are major contributors tomaternal and perinatal morbidity and mortality. The aim of hypertensive therapy is to preventcomplications associated with hypertensive disorders of pregnancy. Objective: To compareefficacy of methyldopa and labetalol in management of pregnancy induced hypertension.Study Design: Randomized control trial. Setting: Punjab medical college and affiliatedhospitals Faisalabad. Methods: Patient were be randomly assigned to either group A or Groupby lottery method. Each group included 157 patients. In group A: labetalol was started at 100mg three or four times a day and increased up to 1200 mg a day in divided doses. In group B:methyldopa was started at 250mg per day 3 to 4 divided doses and increased up to 500 mg in 3to 4 divided doses. Blood pressure was recorded by sphygmomanometer. Blood pressure wasrecorded after 48 hours and then weekly till term on outpatient basis. Results: The treatmentof methyldopa in group I was proved to successful in lowering the mean blood pressure andmaintaining mean blood pressure within normal limits in 142 of 155 patients. It can be said itwas successful in 91.61% cases. 8.39% cases progressed to severe hypertension or eclampsiabecause methyldopa was unsuccessful to prevent progress of disease. Conclusion: It isconcluded that antihypertensive therapy such as methyldopa and labetalol are successful inlowering blood pressure in patient with pregnancy induced hypertension.

About this research paper

What this paper is about

Introduction: The hypertensive Disorders of pregnancy are major contributors tomaternal and perinatal morbidity and mortality. The aim of hypertensive therapy is to preventcomplications associated with hypertensive disorders of pregnancy. Objective: To compareefficacy of methyldopa and labetalol in management of pregnancy induced hypertension.Study Design: Randomized control trial. Setting: Punjab medical college and affiliatedhospitals Faisalabad. Methods: Patient were be randomly assigned to either group A or Groupby lottery method. Each group included 157 patients. In group A: labetalol was started at 100mg three or four times a day and increased up to 1200 mg a day in divided doses. In group B:methyldopa was started at 250mg per day 3 to 4 divided doses and increased up to 500 mg in 3to 4 divided doses. Blood pressure was recorded by sphygmomanometer. Blood pressure wasrecorded after 48 hours and then weekly till term on outpatient basis. Results: The treatmentof methyldopa in group I was proved to successful in lowering the mean blood pressure andmaintaining mean blood pressure within normal limits in 142 of 155 patients. It can be said itwas successful in 91.61% cases. 8.39% cases progressed to severe hypertension or eclampsiabecause methyldopa was unsuccessful to prevent progress of disease. Conclusion: It isconcluded that antihypertensive therapy such as methyldopa and labetalol are successful inlowering blood pressure in patient with pregnancy induced hypertension.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Introduction: The hypertensive Disorders of pregnancy are major contributors tomaternal and perinatal morbidity and mortality. The aim of hypertensive therapy is to preventcomplications associated with hypertensive disorders of pregnancy. Objective: To compareefficacy of methyldopa and labetalol in management of pregnancy induced hypertension.Study Design: Randomized control trial. Setting: Punjab medical college and affiliatedhospitals Faisalabad. Methods: Patient were be randomly assigned to either group A or Groupby lottery method. Each group included 157 patients. In group A: labetalol was started at 100mg three or four times a day and increased up to 1200 mg a day in divided doses. In group B:methyldopa was started at 250mg per day 3 to 4 divided doses and increased up to 500 mg in 3to 4 divided doses. Blood pressure was recorded by sphygmomanometer. Blood pressure wasrecorded after 48 hours and then weekly till term on outpatient basis. Results: The treatmentof methyldopa in group I was proved to successful in lowering the mean blood pressure andmaintaining mean blood pressure within normal limits in 142 of 155 patients. It can be said itwas successful in 91.61% cases. 8.39% cases progressed to severe hypertension or eclampsiabecause methyldopa was unsuccessful to prevent progress of disease. Conclusion: It isconcluded that antihypertensive therapy such as methyldopa and labetalol are successful inlowering blood pressure in patient with pregnancy induced hypertension.

Key concepts: Labetalol, Medicine, Methyldopa, Blood pressure, Pregnancy, Hypertension in Pregnancy, Anesthesia, Sphygmomanometer

Related papers

Back to paper searchBrowse research topicsOriginal source
PREGNANCY INDUCED HYPERTENSION; TO COMPARE EFFICACY OF METHYLDOPA AND LABETALOL IN MANAGEMENT — Research Paper | ScholarLens